These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat. Hussain Y, Güzelhan C, Odink J, van der Beek EJ, Hartmann D. J Clin Pharmacol; 1994 Nov; 34(11):1121-5. PubMed ID: 7876405 [Abstract] [Full Text] [Related]
4. Influence of dietary composition on the inhibition of fat absorption by orlistat. Güzelhan C, Odink J, Niestijl Jansen-Zuidema JJ, Hartmann D. J Int Med Res; 1994 Nov; 22(5):255-65. PubMed ID: 7867870 [Abstract] [Full Text] [Related]
6. Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers. Zhi J, Moore R, Kanitra L, Mulligan TE. J Clin Pharmacol; 2003 Apr; 43(4):428-35. PubMed ID: 12723464 [Abstract] [Full Text] [Related]
9. The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers. Melia AT, Zhi J, Koss-Twardy SG, Min BH, Smith BL, Freundlich NL, Arora S, Passe SM. J Clin Pharmacol; 1995 Aug; 35(8):840-3. PubMed ID: 8522642 [Abstract] [Full Text] [Related]
11. The effect of short-term (21-day) orlistat treatment on the physiologic balance of six selected macrominerals and microminerals in obese adolescents. Zhi J, Moore R, Kanitra L. J Am Coll Nutr; 2003 Oct; 22(5):357-62. PubMed ID: 14559927 [Abstract] [Full Text] [Related]
12. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Zhi J, Melia AT, Guerciolini R, Chung J, Kinberg J, Hauptman JB, Patel IH. Clin Pharmacol Ther; 1994 Jul; 56(1):82-5. PubMed ID: 8033498 [Abstract] [Full Text] [Related]
13. Orlistat fails to alter postprandial plasma lipid excursions or plasma lipases in normal-weight male volunteers. Shepard TY, Jensen DR, Blotner S, Zhi J, Guerciolini R, Pace D, Eckel RH. Int J Obes Relat Metab Disord; 2000 Feb; 24(2):187-94. PubMed ID: 10702769 [Abstract] [Full Text] [Related]
15. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study. Froehlich F, Hartmann D, Guezelhan C, Gonvers JJ, Jansen JB, Fried M. Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450 [Abstract] [Full Text] [Related]
16. Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men. Pace DG, Blotner S, Guerciolini R. J Nutr; 2001 Jun; 131(6):1694-9. PubMed ID: 11385055 [Abstract] [Full Text] [Related]
17. Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects. Ahnen DJ, Guerciolini R, Hauptman J, Blotner S, Woods CJ, Wargovich MJ. Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1291-9. PubMed ID: 17920338 [Abstract] [Full Text] [Related]
18. A one-year trial to assess the value of orlistat in the management of obesity. James WP, Avenell A, Broom J, Whitehead J. Int J Obes Relat Metab Disord; 1997 Jun; 21 Suppl 3():S24-30. PubMed ID: 9225173 [Abstract] [Full Text] [Related]
19. The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers. Melia AT, Mulligan TE, Zhi J. J Clin Pharmacol; 1996 Jul; 36(7):654-8. PubMed ID: 8844449 [Abstract] [Full Text] [Related]
20. The influence of orlistat on the pharmacokinetics and pharmacodynamics of glyburide in healthy volunteers. Zhi J, Melia AT, Koss-Twardy SG, Min B, Guerciolini R, Freundlich NL, Milla G, Patel IH. J Clin Pharmacol; 1995 May; 35(5):521-5. PubMed ID: 7657854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]